DOD Biotech PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	129.23	223.09	67.99	30.27	161.68
Short-Term Investments	160.77	-	-	-	-
Trading Asset Securities	0.03	-	-	-	-
Cash & Short-Term Investments	290.02	223.09	67.99	30.27	161.68
Cash Growth	30.00%	228.12%	124.62%	-81.28%	13.06%
Accounts Receivable	52.63	24.37	82.29	39.05	315.37
Other Receivables	19.56	17.74	29.26	17.69	22.07
Receivables	72.19	42.1	111.55	56.74	337.44
Inventory	111.92	126.88	150.4	98.03	113.46
Other Current Assets	23.2	224.48	42.01	12.09	13.42
Total Current Assets	497.33	616.55	371.96	197.13	626
Property, Plant & Equipment	507.66	511.33	915.83	963	961.03
Long-Term Investments	2.77	2.6	2.6	2.6	2.6
Goodwill	0.25	0.25	0.25	-	-
Other Intangible Assets	37.04	43.06	50.48	5.57	5.66
Long-Term Deferred Tax Assets	92.6	95.5	90.64	92.54	7.9
Other Long-Term Assets	16.31	17.02	25.89	30.08	23.8
Total Assets	1,154	1,286	1,458	1,291	1,627
Accounts Payable	42.67	39.23	75.4	80.44	93.09
Accrued Expenses	24.08	22.5	25.25	17.17	13.64
Short-Term Debt	-	45	110.49	148.7	77
Current Portion of Long-Term Debt	12.92	-	2.12	19.81	28.76
Current Portion of Leases	0.29	0.77	2.8	2.62	4.92
Current Income Taxes Payable	1.96	1.72	21.18	1.66	-
Current Unearned Revenue	18.67	234.83	27.23	-	-
Other Current Liabilities	15.61	21.93	18.32	33.71	41.74
Total Current Liabilities	116.19	365.98	282.8	304.11	259.16
Long-Term Debt	57.14	-	-	2.12	19.31
Long-Term Leases	-	0.29	53.29	55.82	53.31
Pension & Post-Retirement Benefits	13.34	10.59	10.72	7.68	5.37
Long-Term Deferred Tax Liabilities	6.92	10.95	18.49	10.68	12.05
Other Long-Term Liabilities	6.53	6.6	12.29	16.87	15.5
Total Liabilities	200.13	394.4	377.58	397.29	364.7
Common Stock	225.21	225.21	225.21	205	205
Additional Paid-In Capital	651.33	947.27	1,051	890.85	890.85
Retained Earnings	81.79	-273.87	-225.16	-233.86	164.47
Comprehensive Income & Other	-	-	7.35	25.17	20.24
Total Common Equity	958.33	898.6	1,058	887.15	1,281
Minority Interest	-4.49	-6.69	22.12	6.48	-18.26
Shareholders' Equity	953.84	891.91	1,080	893.63	1,262
Total Liabilities & Equity	1,154	1,286	1,458	1,291	1,627
Total Debt	70.35	46.06	168.69	229.08	183.3
Net Cash (Debt)	219.68	177.03	-100.7	-198.81	-21.62
Net Cash Growth	24.09%	-	-	-	-
Net Cash Per Share	0.49	0.39	-0.23	-0.48	-0.05
Filing Date Shares Outstanding	450.41	450.41	450.41	410	410
Total Common Shares Outstanding	450.41	450.41	450.41	410	410
Working Capital	381.14	250.58	89.16	-106.98	366.85
Book Value Per Share	2.13	2.00	2.35	2.16	3.12
Tangible Book Value	921.03	855.29	1,007	881.58	1,275
Tangible Book Value Per Share	2.04	1.90	2.24	2.15	3.11
Land	153.48	153.48	218.87	218.87	218.87
Buildings	343.16	330.42	629.76	535.29	482.56
Machinery	233.26	199.85	297.4	275.58	228.29
Construction In Progress	10.91	26.62	13.71	109.92	159.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.